The appropriate management of occult cervical lymph node metastasis in differentiated thyroid carcinoma (DTC) is controversial.
1 Subclinical lymph node metastasis can be found in 27% to 90% of patients with DTC at the time of surgery or histologic examination.
2-4 Although DTC has a high predilection to spread to regional lymph nodes, the prognostic significance of such regional metastasis is unclear. It has been shown that, in subsets of patients with DTC, particularly those younger than 45 years, lymph node metastasis is not associated with a decrease in survival.
5,6 Other reports, on the contrary, state that lymph node metastasis is a significant prognostic factor that increases the risk of locoregional recurrence
3,7,8 and survival.
9,10 The presence of cervical lymph node metastasis can account for up to 75% of locoregional recurrence cases.
11 In such instances, associated neck dissection improves the prognosis of patients with high-risk DTC.
12